Sonamona Health And Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-10-2024
- Paid Up Capital ₹ 20.00 K
as on 27-10-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -523.24%
(FY 2023)
- Ebitda -429.49%
(FY 2023)
- Net Worth -415.49%
(FY 2023)
- Total Assets 84408.71%
(FY 2023)
About Sonamona Health And Research
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 20.00 K , as per Ministry of Corporate Affairs (MCA) records.
Dilpreet Oberoi, Jatinder Kapur, Rahul Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U33203UP2021PTC150492
- Company No.
150492
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2021
- Date of AGM
30 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sonamona Health And Research?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Jain  | Additional Director | 17-Apr-2024 | Current |
| Jatinder Kapur | Director | 21-Sep-2022 | Current |
| Dilpreet Oberoi | Director | 21-Sep-2022 | Current |
| Tanya Jain | Additional Director | 17-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Sonamona Health And Research.
Sonamona Health And Research Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 523.24% decrease in profit. The company's net worth observed a substantial decline by a decrease of 415.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sonamona Health And Research?
In 2023, Sonamona Health And Research had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ntpr Medicare Private LimitedActive 3 years 4 months
Dilpreet Oberoi and Jatinder Kapur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sonamona Health And Research?
Unlock and access historical data on people associated with Sonamona Health And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sonamona Health And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sonamona Health And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
